openPR Logo
Press release

RNA Sequencing Market is Set to grow at healthy CAGR from 2023 to 2032 | Latest Trends, Revenue Growth & Key Companies

10-16-2023 02:33 PM CET | Health & Medicine

Press release from: allied market research

/ PR Agency: allied market research
RNA Sequencing Market is Set to grow at healthy CAGR from 2023

According to a new report published by Allied Market Research, RNA Sequencing Market, RNA sequencing or whole transcriptome shotgun sequencing is a process to identify the presence and quantity of RNA present in a biological sample. It enables to analyze the constantly changing cellular transcriptome; identifies gene fusion, post transcriptional modifications, & splicing; and recognizes the exon/intron boundary of the eukaryotic genes.

Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-toc-and-sample/2980

RNA Sequencing Market is segmented on the basis of technology, product, end user, and geography. Based on technology, the market is categorized into nucleic acid testing (NAT), ELISA, rapid tests, western blot assay, and next-generation sequencing (NGS).

Key Takeaways:

Explosive Growth: The RNA sequencing market has experienced remarkable growth over the past decade. This growth is driven by advancements in sequencing technologies, reduced costs, and expanding applications in research and clinical settings.

Precision Medicine: RNA sequencing plays a pivotal role in precision medicine. It enables researchers and healthcare professionals to analyze gene expression patterns at the individual level, tailoring treatments for various diseases, including cancer and genetic disorders.

Biomedical Research: RNA sequencing has revolutionized biomedical research by providing insights into gene expression, alternative splicing, and post-transcriptional modifications. This technology helps unravel the complexities of diseases and accelerates the development of therapies.

Single-Cell Sequencing: Single-cell RNA sequencing is a game-changer. It allows researchers to analyze individual cells within a heterogeneous population, leading to a deeper understanding of cell diversity, development, and disease mechanisms.

Clinical Diagnostics: RNA sequencing is increasingly used in clinical diagnostics for disease prognosis, monitoring treatment response, and identifying potential therapeutic targets. It has the potential to transform patient care and outcomes.

Bioinformatics and Data Challenges: With the vast amount of data generated in RNA sequencing experiments, bioinformatics and data analysis tools are critical. The market for RNA sequencing data analysis and interpretation is expanding in parallel with the technology itself.

Competitive Landscape: The market is highly competitive, with several key players offering sequencing platforms and services. Continuous innovation and partnerships are common strategies to stay ahead in the field.

Cost Reduction: The ongoing efforts to reduce the cost of RNA sequencing are making this technology more accessible to a wider range of researchers and institutions.

Key Benefits :

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.

Comprehensive analysis of all geographical regions is provided, which helps to determine the prevailing opportunities.

Key players are profiled and their strategies are analyzed thoroughly, which help to understand competitive outlook of the global market.

The report offers a quantitative analysis which is expected to enable the stakeholders to capitalize on prevailing market opportunities.

Exhaustive analysis of the RNA sequencing market by type helps to understand the types of sequencing technologies that are currently being used along with the variants that are expected to gain prominence in the future.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2980

Competitive Landscape:

Sigma Aldrich

GE Healthcare

Thermo Fisher Scientific Inc.

F. Hoffmann-La Roche Ltd.

Affymetrix Inc.

Agilent Technologies Inc.

Fluidigm Corporation

Bio-Rad Laboratories Inc.

Qiagen N.V.

Market Segments:

By Product & Service:

Sequencing Platforms & Consumables for RNA Sequencing

RNA Sequencing Services

Data Analysis, Storage, and Management

By Technology :

Sequencing by Synthesis (SBS)

Ion Semiconductor Sequencing

Single-molecule Real-time (SMRT) Sequencing

Nanopore Sequencing

By Application:

De Novo Transcriptome Assembly

Expression Profiling Analysis

Variant Calling & Transcriptome Epigenetics

Small RNA Sequencing

By End User :

Blood Banks

Hospitals

Market By Geography:

North America

Europe

Asia-Pacific

LAMEA

Obtain Report Details:

https://www.alliedmarketresearch.com/rna-sequencing-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Web: www.alliedmarketresearch.com

Allied Market Research Blog: https://blog.alliedmarketresearch.com

Follow Us on | Facebook | LinkedIn | YouTube

About Us :

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RNA Sequencing Market is Set to grow at healthy CAGR from 2023 to 2032 | Latest Trends, Revenue Growth & Key Companies here

News-ID: 3251386 • Views:

More Releases from allied market research

Sustainable Tourism Market Size Worth USD 11.4 trillion By 2032 | Growth Opportunities and In-Depth Analysis
Sustainable Tourism Market Size Worth USD 11.4 trillion By 2032 | Growth Opportu …
According to a new report published by Allied Market Research, titled, "Sustainable Tourism Market" The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. In 2023, the coastal tourism segment occupied the largest market share as it is one of the most popular types of sustainable tourism locations in the world due to
Dermocosmetics Market is slated to increase at a CAGR of 11.1% to reach a valuation of $130.46 billion
Dermocosmetics Market is slated to increase at a CAGR of 11.1% to reach a valuat …
The global Dermocosmetics market size was valued at $51.10 billion in 2021, and is projected to reach $130.46 billion by 2030, growing at a CAGR of 11.1% from 2022 to 2030. The Dermocosmetics Market report defines and outlines the products, applications, and specifications to the reader. The study lists the leading companies operating in the Market and highlights the key change processes that companies have adopted to maintain their strengths.
Vegan Cosmetics Market is slated to increase at a CAGR of 5.9% to reach a valuation of $28.5 billion by 2031
Vegan Cosmetics Market is slated to increase at a CAGR of 5.9% to reach a valuat …
According to a new report published by Allied Market Research, titled, "Vegan Cosmetics Market," The vegan cosmetics market size was valued at $16.6 billion in 2021, and is estimated to reach $28.5 billion by 2031, growing at a CAGR of 5.9% from 2022 to 2031. ➡️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 & 𝐓𝐎𝐂 : https://www.alliedmarketresearch.com/request-sample/16708 Vegan cosmetics are made up of chemical compounds taken from natural or synthetic sources that do not contain any
Astrology Market Accelerate at 5.7% CAGR , USD 22.8 billion Incremental Growth
Astrology Market Accelerate at 5.7% CAGR , USD 22.8 billion Incremental Growth
According to the report published by Allied Market Research, the global astrology market has witnessed growth valued at $12.8 billion in 2021, and is projected to reach $22.8 billion by 2031, registering a CAGR of 5.7% from 2023 to 2032. This report analyses the market dynamics, futuristic trends & developments, and segmentation overview. ➡️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 & 𝐓𝐎𝐂 : https://www.alliedmarketresearch.com/request-sample/32229 • Online Platforms and mobile apps provide wider access Technology makes astrology

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and